← Leaderboards
Qingshan Qu
New York University School Of Medicine
$451,150
Attributed
$451,150
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $268K · FY2009–10$500K$375K$250K$125K$0
'09
'10
Funding mix
By agency
NIH$451,150 · 1
CDC$0 · 1
By mechanism
R21$451,150 · 2
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Morton Lippmann$1,151,998
- Beverly Cohen$1,151,998
- Eric Moon-Shong M Tang$13,802,587
- Charles Lockwood$12,124,373
- Jerome P Vanderberg$2,188,061
Others in their field
Top investigators on “Biomarker”
- David R. Weir · University Of Michigan At Ann Arbor$368,126,077
- Leonard Freedman · Leidos Biomedical Research, Inc.$248,231,562
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$217,859,034
- Ralph Parchment · Leidos Biomedical Research, Inc.$186,322,680
- Randall J Bateman · Washington University$182,177,358
- Paul S. Aisen · Cognition Therapeutics, Inc.$182,141,353
Research focus
BiomarkerAir PollutantsAreaAlbuminsAnimalsApolipoprotein EAir SamplingAtherosclerosisBaseBehaviorBenzopyrenesAirborne Particulate MatterBlood ChemistryBlood SpecimenBreathingCaliberCancer RiskCarbopolycyclic CompoundCardiacCardiovascular DiseasesCardiovascular Disorder RiskCardiovascular SystemCessation Of LifeAdmission Activity
Grant awards (6)
Mechanism of ambient particulate matter assosicated cardiovascular diseases: a fe$183,150
R21 · FY2010 · ES · contact PI
Mechanism of ambient particulate matter assosicated cardiovascular diseases: a fe$240,000
R21 · FY2009 · ES · contact PI
Mechanism of ambient particulate matter assosicated cardiovascular diseases: a fe$28,000
R21 · FY2009 · ES · contact PI
Validation of Biomarkers in Humans Exposed to PAHs$0
R21 · FY2004 · OH
Validation of Biomarkers in Humans Exposed to PAHs$0
R21 · FY2003 · OH
Validation of Biomarkers in Humans Exposed to PAHs$0
R21 · FY2002 · OH